Fonar Total Assets 2006-2019 | FONR

Fonar total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Fonar Annual Total Assets
(Millions of US $)
2019 $134
2018 $118
2017 $99
2016 $85
2015 $76
2014 $77
2013 $73
2012 $34
2011 $32
2010 $22
2009 $28
2008 $35
2007 $41
2006 $57
2005 $76
Fonar Quarterly Total Assets
(Millions of US $)
Q4 2019 $134
Q3 2019 $127
Q2 2018 $123
Q1 2018 $120
Q4 2018 $118
Q3 2018 $107
Q2 2017 $105
Q1 2017 $101
Q4 2017 $99
Q3 2017 $92
Q2 2016 $88
Q1 2016 $86
Q4 2016 $85
Q3 2016 $82
Q2 2015 $80
Q1 2015 $79
Q4 2015 $76
Q3 2015 $75
Q2 2014 $79
Q1 2014 $79
Q4 2014 $77
Q3 2014 $76
Q2 2013 $77
Q1 2013 $76
Q4 2013 $73
Q3 2013 $73
Q2 2012 $37
Q1 2012 $35
Q4 2012 $34
Q3 2012 $35
Q2 2011 $33
Q1 2011 $33
Q4 2011 $32
Q3 2011 $26
Q2 2010 $24
Q1 2010 $22
Q4 2010 $22
Q3 2010 $23
Q2 2009 $25
Q1 2009 $27
Q4 2009 $28
Q3 2009 $30
Q2 2008 $33
Q1 2008 $33
Q4 2008 $35
Q3 2008 $41
Q2 2007 $41
Q1 2007 $42
Q4 2007 $41
Q3 2007 $48
Q2 2006 $53
Q1 2006 $54
Q4 2006 $57
Q3 2006 $62
Q2 2005 $69
Q1 2005 $70
Q4 2005 $76
Q3 2005 $75
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.127B $0.087B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.122B 20.23
Abbott Laboratories (ABT) United States $141.639B 26.63
Stryker (SYK) United States $79.044B 27.33
Boston Scientific (BSX) United States $52.905B 25.66
Baxter (BAX) United States $44.730B 27.12
EssilorLuxottica Societe Anonyme (ESLOY) France $31.899B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.527B 17.62
Coloplast (CLPBY) Denmark $24.516B 39.14
Lonza Group Ag (LZAGY) Switzerland $24.500B 0.00
Terumo (TRUMY) Japan $23.332B 26.83
Smith & Nephew SNATS (SNN) United Kingdom $20.451B 0.00
ResMed (RMD) United States $18.758B 35.74
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.664B 51.80
Insulet (PODD) United States $9.336B 553.21
Canopy Growth (CGC) Canada $7.103B 0.00
Perrigo (PRGO) Ireland $7.075B 13.03
Hill-Rom Holdings (HRC) United States $6.550B 19.53
Haemonetics (HAE) United States $6.367B 48.05
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.645B 0.00
Neogen (NEOG) United States $3.284B 54.96
NuVasive (NUVA) United States $3.263B 26.01
ICU Medical (ICUI) United States $3.151B 20.44
Quidel (QDEL) United States $2.356B 23.39
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.303B 0.00
Agios Pharmaceuticals (AGIO) United States $1.869B 0.00
National Vision Holdings (EYE) United States $1.827B 39.44
Cardiovascular Systems (CSII) United States $1.586B 0.00
Aphria (APHA) $1.164B 0.00
VAREX IMAGING (VREX) United States $1.064B 24.53
AtriCure (ATRC) United States $0.978B 0.00
Phibro Animal Health (PAHC) United States $0.849B 13.81
Eagle Pharmaceuticals (EGRX) United States $0.823B 20.97
Omeros (OMER) United States $0.745B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
PetIQ (PETQ) United States $0.722B 17.07
Lantheus Holdings (LNTH) United States $0.721B 18.96
Cerus (CERS) United States $0.623B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.89
Surmodics (SRDX) United States $0.569B 108.08
MacroGenics (MGNX) United States $0.553B 0.00
Quanterix (QTRX) United States $0.529B 0.00
TG Therapeutics (TGTX) United States $0.491B 0.00
OraSure Technologies (OSUR) United States $0.461B 21.34
Owens & Minor (OMI) United States $0.410B 12.28
Meridian Bioscience (VIVO) United States $0.377B 11.76
Zynex (ZYXI) United States $0.362B 38.41
Utah Medical Products (UTMD) United States $0.349B 25.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.312B 0.00
BioLife Solutions (BLFS) United States $0.304B 93.44
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.167B 0.00
Rockwell Medical (RMTI) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.137B 0.00
Female Health (VERU) United States $0.134B 0.00
Chimerix (CMRX) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.084B 19.84
Nephros (NEPH) United States $0.068B 0.00
MTech Acquisition (KERN) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00